1. Pink Sheet

Drug Promotion: Growth In Digital Marketing Warrants New Oversight Approaches, Experts Say

 
• By Sue Sutter

Panelists at a recent Duke-Margolis meeting cite growing use of native ads and patient influencers, as well as the limited attention given to presentation of risk information, in calling for a re-examination of how pharmaceutical promotion on digital platforms is regulated.

digital marketing
The digital marketing landscape is a dynamic and rapidly evolving ecosystem of platforms, technologies and strategies, FDA's Catherine Gray says. • Source: Shutterstock

Regulatory agencies such as the US Food and Drug Administration and the Federal Trade Commission need new tools and approaches to adapt their regulatory oversight of prescription drug promotion to emerging platforms and marketing strategies in the digital age, experts said.

The Duke-Margolis Center for Health Policy, under a cooperative agreement with the FDA, convened a 14 September meeting on the future of prescription drug promotion and digital marketing

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Conferences